In addition to this, a study exploring the role of phosphorylated AR in breast cancer progression noted that particularly in ERα –ve and invasive ductal carcinoma types, there was higher levels of phosphorylated AR in the cytoplasm than the nucleus (130). This evidence concerns the gene AR and invasive ductal breast carcinoma.